EGFR-TKIs Plus PD-1 in EGFR-Mutant Advanced NSCLC

Clinical trial NCT07637448 · RECRUITING

Trial details

NCT number: NCT07637448
Sponsor: Nanfang Hospital, Southern Medical University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-Small Cell Cancer (NSCLC)EGFR Activating Mutation PD-1 Antibody

Start date: 2026-05-21
Primary completion: 2029-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.